Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05518981 · ClinicalTrials.gov registry record
Effect of Remote Physiologic Monitoring (RPM) on Outcomes in COPD Patients
A clinical trial, sponsored by Spire.
- Completed
- Registry status
- 126
- Enrollment target
NCT05518981: Completed study, sponsored by Spire.
NCT05518981 is a clinical trial that has completed, run by Spire. The registered enrollment target is 126 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05518981 has completed, sponsored by Spire.
- COMPLETED
- Registry status
- 126 participants
- Enrollment target
Study Summary
This pre/post study was a retrospective analysis of unplanned hospitalization rates in a cohort of COPD subjects started on remote physiologic monitoring (RPM) at a large, outpatient pulmonary practice. The study included all subjects with high healthcare utilization (≥1 hospitalization or emergency room visit in the prior year) who had elected to enroll in an RPM service for assistance with clinical management. Additional inclusion criteria included being on RPM for at least 12 months and a patient of the practice for at least two years (12 months pre- and post-initiation of RPM).
Primary Outcome
The change in number of all-cause hospitalizations per patient
Interventions
- DEVICE Respiratory Remote Patient Monitor (Spire Health Tag)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2022-02-28 |
What the finished NCT05518981 record still lists
NCT05518981 is an observational study that tracks outcomes without assigning an intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Respiratory Remote Patient Monitor (Spire Health Tag) is the first listed.
NCT05518981 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05518981 about?
NCT05518981 is a clinical study titled "Effect of Remote Physiologic Monitoring (RPM) on Outcomes in COPD Patients". This pre/post study was a retrospective analysis of unplanned hospitalization rates in a cohort of COPD subjects started on remote physiologic monitoring (RPM) at a large, outpatient pulmonary practice. The study included all subjects with high healthcare utilization (≥1 hospitalization or emergency...
What is the current status of trial NCT05518981?
This trial is currently completed. The enrollment target is 126 participants. The study started on 2019-05-01. Estimated completion is 2022-02-28.
What interventions are being tested in trial NCT05518981?
The interventions under investigation include: Respiratory Remote Patient Monitor (Spire Health Tag) (DEVICE).
Who is sponsoring clinical trial NCT05518981?
This trial is sponsored by Spire, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI